Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Application Obtained by HY-1016 Sustain-released Injection

About this update from Sichuan Huiyu Pharmaceutical Co. Ltd. Class A

Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Application Obtained by HY-1016 Sustain-released Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sichuan Huiyu Pharmaceutical Co. Ltd. Class A